← GLP-1 receptor agonists × quality of life & behaviour

Observational studyJAMA network open2025

Factors Associated With Semaglutide Initiation Among Adults With Obesity.

Meghan I Podolsky et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 456 people · 2025

Not counted

Probably raised quality of life & behaviour

2.3×2× to 2.6×

Bigger than 9 in 10 on the map

As reported

OR 2.30, 95% CI 2.05–2.58

Not counted

Probably raised quality of life & behaviour

+62%+46% to +78%

Bigger than 7 in 10 on the map

As reported

OR 1.62, 95% CI 1.46–1.78

Two numbers in the abstract

the abstract, start to end

… being female (adjusted odds ratio [aOR], 2.30; 95% CI, 2.05-2.58), use of certain medication classes including antidepressants (aOR,1.62; 95% CI, 1.46-1.78), and being …

← favours treatmentfavours comparator →
could be chance
Quality of life & behaviour
OR 2.302.05–2.58
Quality of life & behaviour
OR 1.621.46–1.78
GLP-1 receptor agonistsQuality of life & behaviour
1 / 3

15 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39836425